Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KU.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
XBB.1.5.55SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HH.8.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FM.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
FK.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
XBB.2.7.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.8.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EU.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EJ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BM.1.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
AY.123.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.9.2.2 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBF.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BQ.1.1.37SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BN.1.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
EW.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CH.1.1.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
XBB.2.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
XBPSYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
CH.1.1.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.37SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BN.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BN.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.277SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
AY.28 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.1.272SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.371SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.353SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.407SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.47SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.182SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.218SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.12.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.22 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.128SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.33SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used